Literature DB >> 19698655

Hallucinogenic drug induced states resemble acute endogenous psychoses: results of an empirical study.

E Gouzoulis-Mayfrank1, E Habermeyer, L Hermle, A Steinmeyer, H Kunert, H Sass.   

Abstract

Clinical evidence suggests that hallucinogenic drug-induced altered states of consciousness (ASCs) and the incipient, acute stages of endogenous psychoses share many common phenomenological features. The aim of our study was to assess hallucinogen-like phenomena in endogenous psychotic patients using standardised methods. We examined 93 endogenous psychotic patients, 50 healthy controls and a small group of drug induced psychotic patients (n = 7) with two ASC self-assessment scales (questionnaire APZ = Abnormer Psychischer Zustand = Altered State of Consciousness [Dittrich et al, 1985]; and questionnaire OAV = Abbreviation of the three subscales: Oceanic Boundlessness/Angst = Dread of Ego Dissolution/Visionary Restructuralisation [Bodmer 1989]). Patients were examined shortly after remission of their last acute psychotic episode and they answered the questionnaires referring to the early phase of this episode. Differences in the questionnaire scores were significant between psychotic patients and controls. Drug induced patients had numerically higher scores than endogenous psychotic patients, however these differences were only significant for the APZ total score and the undifferentiated items of the APZ, but not for the three APZ subscale and the OAV scores. More than 50% of the endogenous psychotic patients answered 26% of the APZ-and 43% of the OAV-items with "yes". The OAV total score and the OSE (Ozeanische Selbstentgrenzung = oceanic boundlessness) scores of both questionnaires correlated significantly with BPRS Factor 3 (thought disturbance). Our results support the hypothesis that hallucinogen-like experiences represent common phenomena during the acute stages of endogenous psychoses. Remarkably, these phenomena include subjectively pleasant experiences of the OSE dimension. In the routine clinical assessment of endogenous psychotic patients experiences of this dimension may be more easily overlooked than the negative experiences of the AIA dimension (AIA: Angst vor der Ich-Auflösung = dread of ego dissolution).

Entities:  

Year:  1998        PMID: 19698655     DOI: 10.1016/S0924-9338(99)80686-5

Source DB:  PubMed          Journal:  Eur Psychiatry        ISSN: 0924-9338            Impact factor:   5.361


  14 in total

Review 1.  NMDA receptor antagonist effects, cortical glutamatergic function, and schizophrenia: toward a paradigm shift in medication development.

Authors:  John H Krystal; D Cyril D'Souza; Daniel Mathalon; Edward Perry; Aysenil Belger; Ralph Hoffman
Journal:  Psychopharmacology (Berl)       Date:  2003-09-02       Impact factor: 4.530

2.  Acute effects of ayahuasca on neuropsychological performance: differences in executive function between experienced and occasional users.

Authors:  José Carlos Bouso; Josep Maria Fábregas; Rosa Maria Antonijoan; Antoni Rodríguez-Fornells; Jordi Riba
Journal:  Psychopharmacology (Berl)       Date:  2013-06-21       Impact factor: 4.530

3.  Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairments.

Authors:  André Schmidt; Rosilla Bachmann; Michael Kometer; Philipp A Csomor; Klaas E Stephan; Erich Seifritz; Franz X Vollenweider
Journal:  Neuropsychopharmacology       Date:  2011-10-26       Impact factor: 7.853

4.  Localization of MDMA-induced brain activity in healthy volunteers using low resolution brain electromagnetic tomography (LORETA).

Authors:  E Frei; A Gamma; R Pascual-Marqui; D Lehmann; D Hell; F X Vollenweider
Journal:  Hum Brain Mapp       Date:  2001-11       Impact factor: 5.038

Review 5.  A Cannabinoid Hypothesis of Schizophrenia: Pathways to Psychosis.

Authors:  Rachel Little; Dale D'Mello
Journal:  Innov Clin Neurosci       Date:  2022 Jul-Sep

6.  Prepulse inhibition and genetic mouse models of schizophrenia.

Authors:  Susan B Powell; Xianjin Zhou; Mark A Geyer
Journal:  Behav Brain Res       Date:  2009-05-04       Impact factor: 3.332

Review 7.  Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.

Authors:  A de Bartolomeis; E F Buonaguro; F Iasevoli
Journal:  Psychopharmacology (Berl)       Date:  2012-11-21       Impact factor: 4.530

Review 8.  Serotonergic hallucinogens as translational models relevant to schizophrenia.

Authors:  Adam L Halberstadt; Mark A Geyer
Journal:  Int J Neuropsychopharmacol       Date:  2013-08-13       Impact factor: 5.176

9.  Psychometric evaluation of the altered states of consciousness rating scale (OAV).

Authors:  Erich Studerus; Alex Gamma; Franz X Vollenweider
Journal:  PLoS One       Date:  2010-08-31       Impact factor: 3.240

10.  Brain mechanisms of hallucinogens and entactogens.

Authors:  F X Vollenweider
Journal:  Dialogues Clin Neurosci       Date:  2001-12       Impact factor: 5.986

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.